ArticleThe Journal of clinical investigation2021

Tetracyclines improve experimental lymphatic filariasis pathology by disrupting interleukin-4 receptor-mediated lymphangiogenesis.

Julio Furlong-Silva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.